ClearPoint Neuro Future Growth
Future criteria checks 2/6
ClearPoint Neuro is forecast to grow earnings and revenue by 7.4% and 26.5% per annum respectively while EPS is expected to grow by 10.7% per annum.
Key information
7.4%
Earnings growth rate
10.7%
EPS growth rate
| Medical Equipment earnings growth | 17.5% |
| Revenue growth rate | 26.5% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 27 Aug 2024 |
Recent future growth updates
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
May 09
Analysts Have Made A Financial Statement On ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Yearly Report
Mar 15Recent updates
Investors Appear Satisfied With ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Prospects As Shares Rocket 28%
Sep 14Is ClearPoint Neuro (NASDAQ:CLPT) Weighed On By Its Debt Load?
Aug 16Investors Appear Satisfied With ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Prospects As Shares Rocket 26%
Jul 11ClearPoint Neuro, Inc. (NASDAQ:CLPT) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
May 09ClearPoint Neuro: Macro-Induced Multiple Compression
Apr 25Are ClearPoint Neuro, Inc. (NASDAQ:CLPT) Investors Paying Above The Intrinsic Value?
Apr 19Analysts Have Made A Financial Statement On ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Yearly Report
Mar 15Should You Investigate ClearPoint Neuro, Inc. (NASDAQ:CLPT) At US$6.18?
Jan 04Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet?
Dec 06Is There An Opportunity With ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) 41% Undervaluation?
Nov 06Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way?
Aug 18ClearPoint Neuro, Inc. (NASDAQ:CLPT) Looks Just Right With A 40% Price Jump
Apr 17Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet?
Jan 03ClearPoint Neuro: Continuous Great Execution
Sep 19ClearPoint Neuro: Picks & Shovels Galore
Aug 19ClearPoint Neuro (NASDAQ:CLPT) Has Debt But No Earnings; Should You Worry?
Aug 18ClearPoint Neuro: A 'Picks And Shovels' Biotech Company
Jul 25ClearPoint Neuro: Continuous Execution Despite Covid Headwind
May 20Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way?
Apr 25ClearPoint Neuro: A Strong Recovery Play Once COVID Subsides
Mar 18ClearPoint Neuro (NASDAQ:CLPT) Has Debt But No Earnings; Should You Worry?
Jan 19Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 58 | -14 | N/A | N/A | 1 |
| 12/31/2025 | 39 | -17 | -3 | -3 | 3 |
| 12/31/2024 | 31 | -18 | -10 | -10 | 3 |
| 6/30/2024 | 28 | -18 | -10 | -9 | N/A |
| 3/31/2024 | 26 | -21 | -13 | -12 | N/A |
| 12/31/2023 | 24 | -22 | -15 | -14 | N/A |
| 9/30/2023 | 22 | -22 | -17 | -16 | N/A |
| 6/30/2023 | 22 | -21 | -19 | -18 | N/A |
| 3/31/2023 | 21 | -18 | -19 | -18 | N/A |
| 12/31/2022 | 21 | -16 | -17 | -16 | N/A |
| 9/30/2022 | 20 | -16 | -18 | -17 | N/A |
| 6/30/2022 | 19 | -16 | -17 | -16 | N/A |
| 3/31/2022 | 17 | -16 | -15 | -15 | N/A |
| 12/31/2021 | 16 | -14 | -13 | -13 | N/A |
| 9/30/2021 | 16 | -12 | -12 | -12 | N/A |
| 6/30/2021 | 15 | -9 | -10 | -10 | N/A |
| 3/31/2021 | 14 | -7 | -8 | -8 | N/A |
| 12/31/2020 | 13 | -7 | -8 | -8 | N/A |
| 9/30/2020 | 12 | -7 | -6 | -6 | N/A |
| 6/30/2020 | 12 | -6 | -6 | -5 | N/A |
| 3/31/2020 | 12 | -6 | -5 | -5 | N/A |
| 12/31/2019 | 11 | -6 | -3 | -3 | N/A |
| 9/30/2019 | 10 | -5 | -3 | -3 | N/A |
| 6/30/2019 | 9 | -5 | -3 | -3 | N/A |
| 3/31/2019 | 8 | -6 | -3 | -3 | N/A |
| 12/31/2018 | 7 | -6 | -5 | -5 | N/A |
| 9/30/2018 | 7 | -7 | -6 | -6 | N/A |
| 6/30/2018 | 7 | -7 | -7 | -6 | N/A |
| 3/31/2018 | 7 | -7 | N/A | -7 | N/A |
| 12/31/2017 | 7 | -7 | N/A | -6 | N/A |
| 9/30/2017 | 7 | -7 | N/A | -5 | N/A |
| 6/30/2017 | 7 | -8 | N/A | -5 | N/A |
| 3/31/2017 | 6 | -8 | N/A | -6 | N/A |
| 12/31/2016 | 6 | -8 | N/A | -6 | N/A |
| 9/30/2016 | 6 | -8 | N/A | -6 | N/A |
| 6/30/2016 | 5 | -5 | N/A | -6 | N/A |
| 3/31/2016 | 5 | -7 | N/A | -7 | N/A |
| 12/31/2015 | 5 | -8 | N/A | -9 | N/A |
| 9/30/2015 | 4 | -9 | N/A | -9 | N/A |
| 6/30/2015 | 3 | -13 | N/A | -10 | N/A |
| 3/31/2015 | 4 | -11 | N/A | -9 | N/A |
| 12/31/2014 | 4 | -5 | N/A | -7 | N/A |
| 9/30/2014 | 4 | -4 | N/A | -7 | N/A |
| 6/30/2014 | 4 | -4 | N/A | -6 | N/A |
| 3/31/2014 | 3 | -4 | N/A | -7 | N/A |
| 12/31/2013 | 4 | -7 | N/A | -8 | N/A |
| 9/30/2013 | 5 | -4 | N/A | -8 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CLPT is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: CLPT is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: CLPT is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: CLPT's revenue (26.5% per year) is forecast to grow faster than the US market (8.8% per year).
High Growth Revenue: CLPT's revenue (26.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CLPT's Return on Equity is forecast to be high in 3 years time